Screening of primary gp120 immunogens to formulate the next generation polyvalent DNA prime-protein boost HIV-1 vaccines

Our previous preclinical studies and a Phase I clinical trial DP6-001 have indicated that a polyvalent Env formulation was able to elicit broadly reactive antibody responses including low titer neutralizing antibody responses against viral isolates of subtypes A, B, C and AE. In the current report,...

Full description

Saved in:
Bibliographic Details
Main Authors: Shixia Wang (Author), Te-hui Chou (Author), Anthony Hackett (Author), Veronica Efros (Author), Yan Wang (Author), Dong Han (Author), Aaron Wallace (Author), Yuxin Chen (Author), Guangnan Hu (Author), Shuying Liu (Author), Paul Clapham (Author), James Arthos (Author), David Montefiori (Author), Shan Lu (Author)
Format: Book
Published: Taylor & Francis Group, 2017-12-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available